2325.HK Stock Analysis
23
Uncovered
Yunkang Group Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.669
Dividend yield
0.20 %
Shares outstanding
621.25 B
Yunkang Group Ltd. is an investment holding company, which engages in the provision of medical operation services. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2022-05-18. The firm operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The firm primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.